Avicor combats Covid-19 pandemic

Avicor, reported by HVG (Weekly World Economy) the Hungarian leading economic and political weekly, is working on synthetizing potential drug candidate molecules which inhibit the enzyme responsible for the viral entry of Covid-19 together with a German company.

Avicor Ltd. successfully developed…

Avicor Ltd. successfully developed several new products in the frame of a Hungarian R&D grant (KFI_16-1-2017-0105) for specific enrichment of nucleic acids deriving from diverse biological samples specific for human, bacterial, fungal and viral nucleic acids.

Avicor’s highly effective fluorophore AC-202 in Biotechnologies for Biofuels Journal

[vc_row][vc_column][vc_column_text]Researchers at Aix-Marseille University (France) demonstrated that our new, blue fluorescent dye, AC-202 is effective in both green algae Chlamydomonas reinhardtii and pennate diatom Phaeodactylum tricornutum. They also  prooved that after minimal sample preparation, it can label lipid droplets induced by nitrogen starvation or by inhibitors of the TOR (target of rapamycin) kinase. They found that AC-202 benefits …

Read moreAvicor’s highly effective fluorophore AC-202 in Biotechnologies for Biofuels Journal